U54AG093230
Cooperative Agreement
Overview
Grant Description
Advancing the science of palliative care research across the lifespan (ASCENT) consortium - ASCENT: Overall project summary/abstract
Across the lifespan, people living with serious illness suffer physically, psychosocially and financially.
The health system too often fails to deliver appropriate, effective care and persons with serious illness (PWSI) frequently experience mismatches between their goals for care and the treatments received.
Palliative care (PC) meets the needs of PWSI and their caregivers by focusing on achieving the best possible quality of life while receiving life-prolonging and curative treatments as is congruent with patient goals of care.
PC is appropriate from the point of diagnosis throughout the trajectory of a serious illness for persons of any age, with diagnoses including cancer, Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD), advanced organ diseases (including heart, lung, liver, kidney), stroke, neuro-muscular degenerative diseases, genetic disorders and rare congenital and metabolic disorders, among others.
While there have been significant gains in the past 2 decades, the evidence base to guide and improve PC – and thus to improve the quality of life for PWSI and their caregivers – remains inadequate.
We thus urgently need to expand the PC evidence base and create a robust field capable of creating that evidence base.
The Advancing the Science of Palliative Care Research Across the Lifespan (ASCENT) consortium will be a national consortium of experts in PC that will advance innovative, high-quality research to improve care for people living with serious illness by providing resources and expertise in a coordinated manner.
Specifically, the ASCENT consortium will:
1) Develop the national scientific infrastructure and community needed to advance PC research.
The ASCENT community will include scientists, healthcare systems, community-based organizations, clinicians, advocates, patients and caregivers to inform research priorities, study design, and dissemination strategies to maximize the relevance and impact of ASCENT.
2) Create new PC research knowledge and research methodologies by conducting developmental projects, creating a PC research methodology and career development curriculum, and supporting the work of PC scientists via funding and provision of resources and expert consultation.
3) Foster career development and impact of the PC field by supporting career development and pilot awards, providing access to methodologic consultations, and mentoring scientists.
4) Disseminate PC research findings and facilitate subsequent adoption and implementation, employing a multi-pronged approach to dissemination.
Through these 4 specific aims, the ASCENT consortium will transform the field of PC research, generating new knowledge and methods, developing and expanding the palliative care field, and facilitating implementation to enhance the experience of PWSI and their caregivers across the lifespan.
Across the lifespan, people living with serious illness suffer physically, psychosocially and financially.
The health system too often fails to deliver appropriate, effective care and persons with serious illness (PWSI) frequently experience mismatches between their goals for care and the treatments received.
Palliative care (PC) meets the needs of PWSI and their caregivers by focusing on achieving the best possible quality of life while receiving life-prolonging and curative treatments as is congruent with patient goals of care.
PC is appropriate from the point of diagnosis throughout the trajectory of a serious illness for persons of any age, with diagnoses including cancer, Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD), advanced organ diseases (including heart, lung, liver, kidney), stroke, neuro-muscular degenerative diseases, genetic disorders and rare congenital and metabolic disorders, among others.
While there have been significant gains in the past 2 decades, the evidence base to guide and improve PC – and thus to improve the quality of life for PWSI and their caregivers – remains inadequate.
We thus urgently need to expand the PC evidence base and create a robust field capable of creating that evidence base.
The Advancing the Science of Palliative Care Research Across the Lifespan (ASCENT) consortium will be a national consortium of experts in PC that will advance innovative, high-quality research to improve care for people living with serious illness by providing resources and expertise in a coordinated manner.
Specifically, the ASCENT consortium will:
1) Develop the national scientific infrastructure and community needed to advance PC research.
The ASCENT community will include scientists, healthcare systems, community-based organizations, clinicians, advocates, patients and caregivers to inform research priorities, study design, and dissemination strategies to maximize the relevance and impact of ASCENT.
2) Create new PC research knowledge and research methodologies by conducting developmental projects, creating a PC research methodology and career development curriculum, and supporting the work of PC scientists via funding and provision of resources and expert consultation.
3) Foster career development and impact of the PC field by supporting career development and pilot awards, providing access to methodologic consultations, and mentoring scientists.
4) Disseminate PC research findings and facilitate subsequent adoption and implementation, employing a multi-pronged approach to dissemination.
Through these 4 specific aims, the ASCENT consortium will transform the field of PC research, generating new knowledge and methods, developing and expanding the palliative care field, and facilitating implementation to enhance the experience of PWSI and their caregivers across the lifespan.
Funding Goals
TO ENCOURAGE BIOMEDICAL, SOCIAL, AND BEHAVIORAL RESEARCH AND RESEARCH TRAINING DIRECTED TOWARD GREATER UNDERSTANDING OF THE AGING PROCESS AND THE DISEASES, SPECIAL PROBLEMS, AND NEEDS OF PEOPLE AS THEY AGE. THE NATIONAL INSTITUTE ON AGING HAS ESTABLISHED PROGRAMS TO PURSUE THESE GOALS. THE DIVISION OF AGING BIOLOGY EMPHASIZES UNDERSTANDING THE BASIC BIOLOGICAL PROCESSES OF AGING. THE DIVISION OF GERIATRICS AND CLINICAL GERONTOLOGY SUPPORTS RESEARCH TO IMPROVE THE ABILITIES OF HEALTH CARE PRACTITIONERS TO RESPOND TO THE DISEASES AND OTHER CLINICAL PROBLEMS OF OLDER PEOPLE. THE DIVISION OF BEHAVIORAL AND SOCIAL RESEARCH SUPPORTS RESEARCH THAT WILL LEAD TO GREATER UNDERSTANDING OF THE SOCIAL, CULTURAL, ECONOMIC AND PSYCHOLOGICAL FACTORS THAT AFFECT BOTH THE PROCESS OF GROWING OLD AND THE PLACE OF OLDER PEOPLE IN SOCIETY. THE DIVISION OF NEUROSCIENCE FOSTERS RESEARCH CONCERNED WITH THE AGE-RELATED CHANGES IN THE NERVOUS SYSTEM AS WELL AS THE RELATED SENSORY, PERCEPTUAL, AND COGNITIVE PROCESSES ASSOCIATED WITH AGING AND HAS A SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO EXPAND AND IMPROVE THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding Agency
Place of Performance
Colorado
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 4632% from $200,000 to $9,464,050.
The Regents Of The University Of Colorado was awarded
ASCENT Consortium: Advancing Palliative Care Research Quality of Life
Cooperative Agreement U54AG093230
worth $9,464,050
from the National Institute of Child Health and Human Development in August 2025 with work to be completed primarily in Colorado United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.865 Child Health and Human Development Extramural Research.
The Cooperative Agreement was awarded through grant opportunity Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
8/6/25
Start Date
7/31/30
End Date
Funding Split
$9.5M
Federal Obligation
$0.0
Non-Federal Obligation
$9.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to U54AG093230
Additional Detail
Award ID FAIN
U54AG093230
SAI Number
U54AG093230-544835121
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NT00 NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development
Awardee UEI
MW8JHK6ZYEX8
Awardee CAGE
0P6C1
Performance District
CO-90
Senators
Michael Bennet
John Hickenlooper
John Hickenlooper
Modified: 8/6/25